Bottom Line…Researchers summarize the limited but positive data showing that buprenorphine is an appropriate treatment for adolescents and young adults with opioid use disorders, and discuss dosing and psychosocial treatment protocols.Few adolescents and young adults with opioid use disorders (OUDs) can access treatment, even though medications and psychosocial services are available, researchers wrote in the current issue of the Journal of Addiction Medicine.There have been three randomized controlled trials (RCTs) (see ADAW, Oct. 10, 2005, Nov. 10, 2008, and Oct. 24, 2016), as well as many observational studies, showing the effectiveness of buprenorphine treatment for young people, but until now, they have not been summarized. Based on their summary, the researchers encourage treatment with buprenorphine for adolescents and young adults.Many adolescents and young adults are transitioning from abuse of prescription opioids to heroin, a trend that has made the need for treatment all the more urgent, the researchers wrote. Methadone and buprenorphine are effective components of standard treatment for adults with OUDs. They reduce risk of death, and improve abstinence and treatment retention. A large body of literature supports maintenance treatment.But for adolescents, access to buprenorphine — which unlike methadone does not require daily clinic visits — is restricted.
Alcoholism and Drug Abuse Weekly – Wiley
Published: Jan 12, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera